A $200 million transaction between owner Serán Bioscience and Bain Capital Life Sciences in 2024 helped support the buildout of the commercial-scale plant.
Categories:
Related Post
Roche’s Genentech more than doubles North Carolina facility investment to $2B
The 700,000-square-foot project broke ground in August and is set to produce weight-loss treatments by…
Contractors’ pay strategies hint at stabilizing job market
Salary increases driven by labor shortages and inflation have begun to slow, indicating an easing…
Construction Inclusion Week hits record sponsorship numbers
Despite what it called a “politically charged atmosphere” around DEI, the industry-led initiative said it…